Grace Therapeutics (GRCE) Convertible Debt (2017 - 2020)
Grace Therapeutics' Convertible Debt came in at $187,000 for fiscal Q4 2020 (quarter ended Mar 31, 2020), down 88.2% from $1.58 million a year earlier.
Analysis
Grace Therapeutics (GRCE) Convertible Debt (2017 - 2020) Analysis & Trends
- Going back by fiscal year, Convertible Debt was $1.58 million in FY2019.
- The fiscal Q4 2020 figure represents the lowest quarterly Convertible Debt since fiscal Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 187,000.00 |
| Mar 31, 2019 | 1.58 Mn |
| Jun 30, 2017 | -30,017.09 |
API Access
Grace Therapeutics Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();